Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine composition for treating chronic liver disease

A chronic liver disease and composition technology, applied in the field of pharmaceutical composition for the treatment of chronic liver disease, can solve the problems of not very obvious effect, inconvenient preparation and use, unstable curative effect, etc., achieve exact therapeutic effect, short course of treatment, rigorous and novel prescription Effect

Inactive Publication Date: 2014-01-15
JINSHAN HOSPITAL FUDAN UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the Chinese patent medicines used clinically for the treatment of chronic liver diseases all have certain curative effects, but there are also some problems, such as slow onset of action of some medicines, many medicinal flavors, inconvenient preparation and use, not very obvious effects, long taking time, and poor curative effect. Stable and so on

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine composition for treating chronic liver disease
  • Medicine composition for treating chronic liver disease
  • Medicine composition for treating chronic liver disease

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] Embodiment 1 pharmaceutical composition one

[0026] 20 parts of kiwi fruit juice, 30 parts of salvia miltiorrhiza, 5 parts of Atractylodes macrocephala, 12 parts of epimedium, 4 parts of poria cocos, 6 parts of Bupleurum chinensis, 5 parts of schisandra, 4.5 parts of white cardamom, 2.5 parts of tangerine peel, 15 parts of heterophylla.

Embodiment 2

[0027] Example 2 Pharmaceutical composition two

[0028] 24 parts of kiwi fruit juice, 28 parts of Danshen, 6 parts of Atractylodes macrocephala, 11 parts of Epimedium, 5 parts of Poria, 5 parts of Bupleurum, 6 parts of Schisandra, 4 parts of white Kou, 3 parts of tangerine peel, 14 parts of heterophylla.

Embodiment 3

[0029] Example 3 Pharmaceutical composition three

[0030] 28 parts of kiwi fruit juice, 26 parts of Danshen, 7 parts of Atractylodes macrocephala, 10 parts of epimedium, 6 parts of Poria, 4 parts of Bupleurum, 7 parts of Schisandra, 3.5 parts of white cardamom, 3.5 parts of tangerine peel, and 13 parts of heterophylla.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicine composition for treating chronic liver disease and application thereof. The medicine composition is prepared from the following raw materials in parts by weight: 20-60 parts of kiwi-fruit juice, 10-30 parts of radix salviae miltiorrhizae, 5-15 parts of rhizoma atractylodis macrocephalae, 4-12 parts of herba epimedii, 4-12 parts of poria cocos, 2-6 parts of radix bupleuri, 5-15 parts of fructus schisandrae chinensis, 1.5-4.5 parts of cardamon fruit, 2.5-7.5 parts of tangerine peel and 5-15 parts of radix pseudostellariae. The medicine composition has the advantages that the application of the medicine composition can serve as a basic therapeutic method for regulating deficiency, nourishing yin and detoxifying and can integrate methods of clearing heat and removing toxicity, regulating qi and activating blood, strengthening spleen and harmonizing stomach, nourishing liver and kidney and the like by starting from spleen and kidney; the medicine compatibility according to the prescription strictly conforms to the traditional theory of traditional Chinese medicine and also refers to the optimal configuration of empirical and classical prescriptions, and the formula is strict and novel; the results of clinical and experimental studies prove that the medicine composition provided by the invention has an exact therapeutic effect on the chronic liver disease, is relatively low in cost, has no toxic and side effect, achieves a short course of treatment, a quick effect and a high curate rate, and ensures that the chronic liver disease basically does not relapse after being cured.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a pharmaceutical composition for treating chronic liver disease. Background technique [0002] Chronic liver disease is a common and frequently occurring disease that endangers human health. It has added a heavy burden to the whole society and family. Over the years, new antiviral drugs have emerged continuously, all of which have disadvantages such as high drug costs, toxic and side effects, and unsatisfactory long-term curative effects. Therefore, it is of great social and economic benefit to give full play to the characteristics of traditional Chinese medicine and seek new effective drugs. [0003] Chinese patent document CN101700283A discloses a kind of medicine for the treatment of chronic hepatitis B, which is composed of Chinese herbal medicines such as berberis, notoginseng, phoenix fern, green scorpion seed, melon seed gold, Daxueteng, kiwi fruit root, etc.,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/9064A61P1/16A61P31/20
Inventor 黄骏高鹏飞黄河清杜玉玲强金伟陈英辉陈碧琴武哲丽
Owner JINSHAN HOSPITAL FUDAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products